Search Results 181-190 of 17160 for Hookworm
The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...
The purpose of this study is to see if the investigators can identify early those patients who are admitted to the hospital and have a urinary tract infection ( ...
This study is a randomized, double-blind, placebo controlled clinical study to assess the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of ...
This inherited condition causes polyps to grow in the digestive tract and increases the risk of cancer. Regular screening helps reduce some risks.
The secondary goal is to asses clinical endopoints associated with standard of care therapies for TCR MM, in a real-world setting during 12 months of ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely ...
This condition occurs when your body produces too many platelets, the cells that help blood clot. Thrombocytosis can cause clotting or bleeding problems.
This type of cancer starts in the small intestine. Find out more about symptoms and treatments, including surgery, chemotherapy and targeted therapy.
The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.